Foix-Alajouanine syndrome : Report of a case with spinal cord

Journal of Neurology & Neurophysiology

ISSN - 2155-9562

Foix-Alajouanine syndrome : Report of a case with spinal cord

2nd International Conference and Exhibition on Neurology & Therapeutics

June 17-19, 2013 Hilton Chicago/Northbrook, Chicago, USA

Muhammad Umair Khan, Mostafa Arifa and Bruce Janati

Accepted Abstracts: J Neurol Neurophysiol

Abstract :

Introduction:Foix and Alajouanine first described the syndrome in 2 young men in 1926. It was thought to be a subacute myelopathy produced by a thrombotic process of the spinal cord that ultimately caused death. Objectives: 1. Anti-coagulation is contra-indicated in patients with spinal epidural AVM. 2. Sudden onset of paraplegia in a patient receiving anti-coagulation therapy should immediately raise the suspicion of hemorrhagic transformation of a previously undetected spinal epidural AVM. Methods: This is a clinical and neuroimaging case study. Results: Our patient with a diagnosis of Foix-Alajuannine syndrome developed intramedullary hemorrhage while receiving anticoagulation therapy for prevention of deep vein thrombosis. Conclusion: Our data, for the first time, document objectively the high risk of anticoagulants in spinal arteriovenous malformation, and mitigate against the use of these agents in this syndrome. Biography

Biography :

Muhammad Umair Khan is a 4 th year medical student at Dow University of Health Sciences, Karachi, Pakistan. He is also working as a Research Associate at King Khalid Hospital, Hail, Saudi Arabia.